# Shukun Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shukun-technology

- Industry: Healthcare IT
- Headquarters: Beijing, China
- Website: www.shukun.net
- Total disclosed funding: $213M
- Latest round: Series D (Aug 16, 2021)
- Investors on record: 17

## About

Founded in 2017 and based in Beijing, China, Shukun Technology is a healthcare IT company that provides an artificial intelligence-assisted medical imaging system for disease screening, and diagnosis. Its artificial intelligence (AI) products have NMPA and CE certifications. It acquired the NMPA Class III license, EU MDR CE certification, and U.S. FDA certification. The company cooperated with PHILPS, Health 100, and the People's Government of Songjiang District, Shanghai. In August 2021, Shukun Technology raised a series D funding for CNY 700 million.

Shukun Technology provides disease assistant diagnosis and therapeutic imaging products, Digital Doctor, which supports disease screening, diagnosis, and therapeutic plans for heart, brain, chest, and bone diseases. It also provides a smart scientific research platform, which supports hospital collaboration, multiple center research and development, and multiple tools imaging. Moreover, Shukun Technology offers solutions for smart surgery, smart imaging, and smart health.

The company will use the funding to invest in the research and development of the Digital Human Body platform, improve the product line, and accelerate the research and development of Digital Organ AI-assisted diagnostic and therapeutic products.

## Funding rounds

- Series D, Aug 16, 2021, $108M — Goldman Sachs Asset Management, Primavera Capital Group, Marathon Venture Partners, HSG, WT Asset Management, Sage Partners, Future Qichuang Capital, Jane Street Asia Limited
- Series B, Aug 31, 2020, $29M — Qiming Venture Partners, SPD Silicon Valley Bank, Everest VC, Thunder Software Technology
- Series B, Jun 15, 2020, $28M — BOC International (China), CCB International Asset Management, Huagai Capital, Cyber Creation Ventures (CCV)
- Series B, Feb 18, 2019, $30M — 5Y Capital, Huagai Capital, Marathon Venture Partners, Cyber Creation Ventures (CCV)
- Series A, Jul 3, 2018, $15M — 5Y Capital, Huagai Capital, Marathon Venture Partners
- Angel, Jul 28, 2017, $3.3M — Marathon Venture Partners

## Investors

- Marathon Venture Partners (https://capitalatlas.ai/funds/marathon-venture-partners) — Angel, Series A, Series B, Series D
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A, Series B
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series A, Series B
- Cyber Creation Ventures (CCV) (https://capitalatlas.ai/funds/cyber-creation-ventures-ccv) — Series B
- BOC International (China) (https://capitalatlas.ai/funds/boc-international-china) — Series B
- CCB International Asset Management (https://capitalatlas.ai/funds/ccb-international-asset-management) — Series B
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- SPD Silicon Valley Bank — Series B
- Everest VC (https://capitalatlas.ai/funds/everest-vc) — Series B
- Thunder Software Technology — Series B
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series D
- Primavera Capital Group (https://capitalatlas.ai/funds/primavera-capital-group) — Series D
- HSG (https://capitalatlas.ai/funds/hsg) — Series D
- WT Asset Management — Series D
- Sage Partners (https://capitalatlas.ai/funds/sage-partners) — Series D
- Future Qichuang Capital (https://capitalatlas.ai/funds/future-qichuang-capital) — Series D
- Jane Street Asia Limited — Series D
